Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius medical care malaysia sdn bhd - sodium chloride ph eur; calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium lactate solution (50%) -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - 62048 - gastric ph strip - ph strips to indicate the ph level of human gastric aspirate

Kenya - Inggris - Pharmacy and Poisons Board

irbesartan ph eur and hydrochlorothiazide ph eur - film-coated tablet - each film coated tablet contains: irbesartan ph… - irbesartan and diuretics

Kenya - Inggris - Pharmacy and Poisons Board

irbesartan ph eur and hydrochlorothiazide ph eur - film-coated tablet - each film coated tablet contains: irbesartan ph… - irbesartan and diuretics

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium acetate, quantity: 3.68 g/l; potassium chloride, quantity: 370 mg/l; magnesium chloride hexahydrate, quantity: 300 mg/l; sodium gluconate, quantity: 5.02 g/l; sodium chloride, quantity: 5.26 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections - plasma-lyte 148 (approx. ph 7.4) iv infusion is indicated as a source of water and electrolytes or as an alkalinising agent.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium gluconate, quantity: 5.02 g/l; sodium acetate, quantity: 3.68 g/l; sodium chloride, quantity: 5.26 g/l; magnesium chloride hexahydrate, quantity: 300 mg/l; potassium chloride, quantity: 370 mg/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections - plasma-lyte 148 (approx. ph 7.4) iv infusion is indicated as a source of water and electrolytes or as an alkalinising agent.

Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

farmalinx pty ltd - nonyl phenol ethoxylate; phosphoric acid derivatives - soluble concentrate - nonyl phenol ethoxylate emulsifiers & surfactants-noni active 266.2 g/l; phosphoric acid derivatives mineral-phophorus-acid active 375.1 g/l - adjuvant - wetting agent | spreader | surfactant - spreader spray (refer to directions)

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 420 mg (equivalent: lipase, qty 35000 ph eur unit; equivalent: amylase, qty 25200 ph eur unit; equivalent: protease, qty 1400 ph eur unit) - capsule - excipient ingredients: macrogol 4000; hypromellose phthalate; cetyl alcohol; triethyl citrate; dimeticone 1000; gelatin; iron oxide red; iron oxide yellow; iron oxide black; titanium dioxide; sodium lauryl sulfate - creon is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: ? cystic fibrosis ? chronic pancreatitis ? pancreatic surgery ? gastrointestinal bypass surgery (e.g. bilroth ii gastroenterostomy) ? ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 300mg (amylase 16,000 ph eur u, lipase 20,000 ph eur u, protease 1,200 ph eur u.) - modified release capsule - 300 mg - active: pancreatin 300mg (amylase 16,000 ph eur u, lipase 20,000 ph eur u, protease 1,200 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.); pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) - modified release capsule - 420 mg - active: pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate active: pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).